Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-02-07 @ 7:04 AM
Study NCT ID:
NCT00458159
Status:
TERMINATED
Last Update Posted:
2019-12-13
First Post:
2007-04-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodysplastic Syndromes
Sponsor:
Celgene
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Myelodysplastic Syndrome | View |